IJK - iShares S&P Mid-Cap 400 Growth ETF
| Assets | $8.31B |
| NAV | $81.23 |
| Expense Ratio | 0.17% |
| PE Ratio | 38.69 |
| Beta (5Y) | 1.11 |
| Dividend (ttm) | $0.77 |
| Dividend Yield | 0.95% |
| Ex-Dividend Date | Mar 25, 2021 |
| 1-Year Return | - |
| Trading Day | April 20 |
| Last Price | $80.30 |
| Previous Close | $81.35 |
| Change ($) | -1.05 |
| Change (%) | -1.29% |
| Day's Open | 80.96 |
| Day's Range | 79.80 - 81.52 |
| Day's Volume | 268,383 |
| 52-Week Range | 45.87 - 82.18 |
Fund Description
The investment seeks to track the investment results of the S&P MidCap 400 Growth IndexTM, which measures the performance of the mid-capitalization growth sector of the U.S. equity market. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents, as well as in securities not included in the underlying index, but which the advisor believes will help the fund track the underlying index.
| Asset Class Equity | Sector Mid Cap |
| Region North America | Inception Date Jul 24, 2000 |
| Exchange NYSEARCA | Ticker Symbol IJK |
| Index Tracked S&P MidCap 400 Growth Index | |
Top 10 Holdings
12.82% of assets| Name | Symbol | Weight |
|---|---|---|
| Bio-Techne | TECH | 1.42% |
| PTC Inc. | PTC | 1.39% |
| Charles River Laboratories | CRL | 1.36% |
| Fair Isaac | FICO | 1.35% |
| Cognex | CGNX | 1.34% |
| Williams-Sonoma | WSM | 1.26% |
| SolarEdge Technologies | SEDG | 1.25% |
| Cree, Inc. | CREE | 1.21% |
| Graco | GGG | 1.14% |
| Masimo | MASI | 1.09% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Mar 25, 2021 | $0.091 | Mar 31, 2021 |
| Dec 14, 2020 | $0.153 | Dec 18, 2020 |
| Sep 23, 2020 | $0.128 | Sep 29, 2020 |
| Jun 15, 2020 | $0.402 | Jun 19, 2020 |
| Mar 25, 2020 | $0.507 | Mar 31, 2020 |
| Dec 16, 2019 | $0.755 | Dec 20, 2019 |
Growth stocks, namely tech stocks, have proven to be viral to the COVID economy and resilient. For hungry investors looking for growth and returns, Q.ai's deep learning algorithms have identified the To...
BlackRock's iShares unit reduced expense ratios and enacted splits on several of its ETFs.
Bullish chart patterns suggest that the the mid-cap growth market segment is worth watching over the weeks and months ahead.
While large companies are normally known for stability and the smaller ones for growth, mid-caps offer the best of both worlds, allowing growth and stability in portfolios simultaneously.
For the iShares S&P Mid-Cap 400 Growth ETF (IJK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $251.90 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF (IJK), we found that the implied analyst target price for the ETF based upon its underlying holdings is $248.69 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $247.22 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $248.90 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $248.20 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $248.91 per unit.
For the iShares S&P Mid-Cap 400 Growth ETF, we found that the implied analyst target price for the ETF based upon its underlying holdings is $249.07 per unit.
Investors seeking to capitalize on strong fundamentals but worried about trade war should consider mid-cap stocks in the basket form.
Among the many asset classes that performed well in the first quarter were mid-cap stocks. In the first three months of the year, the S&P MidCap 400 Index returned 14.8 percent, beating the S&P 500 by 1...